Featured Products
Sunkin® Carbomer 940
Sunkin® Carbomer 940
Sunkin® Carbomer 940 is a white powder, crosslinked polyacrylic acid polymer. It is an extremely efficient rheology modifier capable of providing high viscosity and forms sparkling clear gels or hydro-alcoholic gels and creams.
Sunkin® Carbomer 980
Sunkin® Carbomer 980
Sunkin® Carbomer 980 is a white powder, crosslinked polyacrylic acid that is polymerized in a toxicologically-preferred cosolvent system. It is an extremely efficient rheology modifier capable of providing high viscosity and forms sparkling clear gels or
Sunkin® Carbomer 676
Sunkin® Carbomer 676
Sunkin® Carbomer 676 is a highly crosslinked polyacrylic acid polymer. It has short flow characteristics and relatively high viscosity performance. It is recommended for use in automatic dish care, hard surface cleaners, home care cleaning systems
Sunkin® Carbomer U20
Sunkin® Carbomer U20
Sunkin® Carbomer U20 is a white powder, hydrophobically-modified cross-linked acrylate copolymer. This polymer offers many substantial benefits for formulators and marketers of personal care products.
About Us
Xinzihong® was founded in Danzhai County, Guizhou Province, China in 2012. It is a high-tech enterprise focusing on the customized R & D and production of pharmaceutical excipients.

Xinzihong® holds the drug production license issued by the China drug administration. Its products: Carbomer,  Ethylenediamine, Trometamol, N-methylglucamine, Sodium Stearyl Fumarate, Sodium Bicarbonate, Tartaric Acid,Aspartame, Sucrose Particles, etc. all meet the pharmaceutical standards and have been registered in CDE, China. At present, 60% of China's pharmaceutical enterprises are using Xinzihong® products.

Xinzihong® insist on taking R&D and innovation as the foundation, producing drugs and excipients according to pharmaceutical standards, so as to ensure the safety of drugs. We aim to become an excellent global pharmaceutical excipients solution service provider, and bring our brand to the world with the continuous improvement of Xinzihong® spirit.
200+ Staff 200+ Staff 39,500m² Plant 39,500m² Plant 45 Researcher 45 Researcher
Get Stated Now
News And Events
Quality Standard and Detection Method Of Carbomer Copolymer In Chinese Pharmacopoeia
Monday , August 30 , 2021
Quality Standard and Detection Method Of Carbomer Copolymer In Chinese Pharmacopoeia
Quality Standard and Detection Method Of Carbomer Copolymer In Chinese Pharmacopoeia. Carbomer copolymer is a long-chain alkyl methacrylate polymer copolymer of acrylic acid bonded polyols with non benzene solvent as polymerization solvent. According to the dry product, the carboxylic acid group (- cooh) shall be 52.0% ~ 62.0%.
Learn more
Application of Carbomer in Ophthalmic Gel Preparation
Monday , August 30 , 2021
Application of Carbomer in Ophthalmic Gel Preparation
Due to the special eye protection mechanism, such as tear flushing, blinking movement, corneal low permeability and many other physiological factors, ordinary eye drops will be quickly eliminated, drug absorption is limited, and the bioavailability after eye administration is restricted. Improving the bioavailability of drugs in ophthalmic preparations mainly depends on the retention time of drugs in the eye (cornea). The longer the time, the greater the amount of drugs absorbed and the better the curative effect. Some dosage forms such as suspension or eye ointment can stay in the eyes, but solid or semi-solid will make the patient uncomfortable. Carbomer gel has good adhesion, non-toxic and non irritant. It can extend the time of action and increase the absorption and utilization of drugs. The study showed that the contact time between Carbomer gel and eye was concentration dependent.
Learn more
CDE Expert | Analysis and Countermeasures of Drug R&D Quality Management System
Friday , August 27 , 2021
CDE Expert | Analysis and Countermeasures of Drug R&D Quality Management System
Drug R&D involves a wide range of projects, multiple fields and disciplines, with long R&D cycle, large investment amount and significant complexity. During drug R&D, the listing license holder shall formulate the management system and design the drug test plan according to the actual situation of the enterprise, strictly abide by the system and carry out the test according to the test plan, Truthfully record the experimental data to ensure the authenticity, accuracy and integrity of the application data. In this process, the quality management system is the key. The management level of drug R&D quality has a direct impact on the final quality of drugs. This paper mainly analyzes and discusses the characteristics of drug R&D and summarizes the measures to improve the quality management of drug R&D.
Learn more